Chromition

Chromition has developed light-emitting particles known as Luminspheres™ which can be attached to biomarkers that bind to cancer cells and give off light to indicate the presence of cancer. Tissue samples can be screened using existing equipment and the use of pattern recognition software helps speed up the process, rather than relying solely on inspection by clinicians. As different coloured Luminspheres™ can be attached to different biomarkers, multiple cancer screens can be done all at once, saving time, money and potentially lives.